Five technologies invented by scientists at the Department of Energy’s Oak Ridge National Laboratory have been selected for targeted investment through ORNL’s Technology Innovation Program.
Technology developed at ORNL to monitor plant productivity and health at wide scales has been licensed to Logan, Utah-based instrumentation firm Campbell Scientific Inc.
Several electrolyte and thin-film coating technologies, developed at Oak Ridge National Laboratory, have been licensed by BTRY, a battery technology company based in Virginia, to make batteries with increased energy density, at lower cost, and with an i
ORNL, TVA and TNECD were recognized by the Federal Laboratory Consortium for their impactful partnership that resulted in a record $2.3 billion investment by Ultium Cells, a General Motors and LG Energy Solution joint venture, to build a battery cell ma
A novel method to 3D print components for nuclear reactors, developed by the Department of Energy’s Oak Ridge National Laboratory, has been licensed by Ultra Safe Nuclear Corporation.
A new technology for rare-earth elements chemical separation has been licensed to Marshallton Research Laboratories, a North Carolina-based manufacturer of organic chemicals for a range of industries.
ORNL and the University of Oklahoma, known as OU, recently executed a memorandum of understanding to officially recognize their partnership in pursuing shared research and development goals.
In a new twist to an existing award-winning ORNL technology, researchers have developed an electrocatalyst that enables water and carbon dioxide to be split and the atoms recombined to form higher weight hydrocarbons for gasoline, diesel and jet fuel.
The ExOne Company, the global leader in industrial sand and metal 3D printers using binder jetting technology, announced it has reached a commercial license agreement with Oak Ridge National Laboratory to 3D print parts in aluminum-infiltrated boro
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.